The Conversation (0)
December 14, 2021
MJ Group Holdings Limited (ASX: MMJ) is an Australian�listed, specialist investment company that has traded on the ASX since 2015. Investors in MMJ gain exposure to a portfolio which concentrates on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted equities and other financial assets.
Investments are managed by Parallax Ventures Inc., a specialist management company in Canada, under a long�term strategic partnership.Since 2015, MMJ has created a significant number of investment opportunities from its connections in Canada and Australia in the private investment sector and realised exits to the benefit of MMJ and its shareholders:
Click here for the full ASX Release
This article includes content from MMJ Group Holdings, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
MMJ:AU
08 July 2021
MMJ Group Holdings
Building an International Portfolio of Cannabis Investments
Building an International Portfolio of Cannabis Investments Keep Reading...
06 January
Cannabis Market 2025 Year-End Review
2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
18 December 2025
Cannabis Market Forecast: Top Trends for Cannabis in 2026
The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
18 December 2025
Analysts React: Trump Signs Executive Order to Reschedule Cannabis
The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
15 December 2025
Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions
US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
14 November 2025
Hemp THC Recriminalization: A Blow to a Blooming Industry
A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
30 October 2025
Australia's Cannabis Import Quota Slashed Amid Surging Local Production
Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00